Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (Campath-1H)

Allan D. Kirk*, Douglas A. Hale, Roslyn B. Mannon, David E. Kleiner, Steven C. Hoffmann, Robert L. Kampen, Linda K. Cendales, Douglas K. Tadaki, David M. Harlan, John Swanson

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

405 Scopus citations

Fingerprint

Dive into the research topics of 'Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (Campath-1H)'. Together they form a unique fingerprint.

Medicine & Life Sciences